GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biocorp Production SA (FRA:8BP) » Definitions » Additional Paid-In Capital

Biocorp Production (FRA:8BP) Additional Paid-In Capital : €2.86 Mil(As of Dec. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Biocorp Production Additional Paid-In Capital?


Biocorp Production's quarterly additional paid-in capital declined from Dec. 2021 (€20.67 Mil) to Jun. 2022 (€2.86 Mil) but then stayed the same from Jun. 2022 (€2.86 Mil) to Dec. 2022 (€2.86 Mil).

Biocorp Production's annual additional paid-in capital stayed the same from Dec. 2020 (€20.67 Mil) to Dec. 2021 (€20.67 Mil) but then declined from Dec. 2021 (€20.67 Mil) to Dec. 2022 (€2.86 Mil).


Biocorp Production Additional Paid-In Capital Historical Data

The historical data trend for Biocorp Production's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocorp Production Additional Paid-In Capital Chart

Biocorp Production Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.79 16.68 20.67 20.67 2.86

Biocorp Production Semi-Annual Data
Dec12 Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.67 20.67 20.67 2.86 2.86

Biocorp Production Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Biocorp Production Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Biocorp Production's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Biocorp Production (FRA:8BP) Business Description

Traded in Other Exchanges
N/A
Address
Technological Park Lavaur la Bechade, Issoire, FRA, 63500
Biocorp Production SA is engaged in the development, production, and marketing of medical devices and drug delivery systems for the pharmaceutical industry.

Biocorp Production (FRA:8BP) Headlines

No Headlines